Â鶹Éç

Available for over a year

Drugs giant Pfizer has been fined a record £84.2m by the UK's competition watchdog for overcharging the NHS for an anti-epilepsy drug. The Competition and Markets Authority (CMA) also fined distributor Flynn Pharma £5.2m for the 2,600% overnight price increase for the drug in 2012. Michael Grenfell, Executive Director of Enforcement at the CMA, says the price of the drug was "considerably higher than in any other European country". (Image: Pfizer, credit: Getty Images)